Formycon AG FYB
$23.20
▼ -0.10% 24H
About
Formycon AG is a leading independent biotechnology company headquartered in Planegg, Germany, specializing in the development of high-quality biosimilars, which are cost-effective follow-on versions of complex biopharmaceutical medicines. The company focuses on key therapeutic areas such as ophthalmology, immunology, a…
SectorHealthcare
ExchangeXETR
IndustryBiotechnology
CountryGermany
Employees203
TickerFYB
Statistics
Market Cap$410.0M
Revenue (TTM)$60.6M
Net Income—
Net Margin—
EPS—
P/E5.87
P/S6.76
P/B0.89
EV/EBITDA-16.03
ROE-13.4%
Dividend Yield—
Price$23.20
Data: Twelve Data · Revenue = mcap / P/S